Compare Cerus Corporation vs medSage Technologies
Customers evaluate the quality of Cerus Corporation's products using the following success metrics.
Overview
Cerus Corporation is 33 yrs old and is based in United States.
Cerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is currently in clinical development.
medSage Technologies is 21 yrs old and is based in United States.
medSage Technologies aims to provide software and services which enable providers in the Home Medical Equipment (HME) industry to increase supply revenue from current patients by identifying those who require replacement supplies.
Demo Video
Leadership
Arnaud Besnard (Managing Director)
Jerry Connelly (Chief Executive Officer, President)
Investors
LRG Capital Group, Galleon Management
Philips, Pittsburgh Life Sciences Greenhouse
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Cerus Corporation has not claimed their profile.
Work for Cerus Corporation? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Cerus Corporation?
Claim your profile now.
Information not available because medSage Technologies has not claimed their profile.
Work for medSage Technologies? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for medSage Technologies?
Claim your profile now.